Healthcare provider profile · identity verified

Margaret Moore, D.O.

Family Practice · BLOOMSBURG, PA · NPI 1952592578

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	804	264
Levothyroxine Sodium	Levothyroxine Sodium	434	145
Amlodipine Besylate	Amlodipine Besylate	385	125
Lisinopril	Lisinopril	377	135
Omeprazole	Omeprazole	364	124
Rosuvastatin Calcium	Rosuvastatin Calcium	303	123
Gabapentin	Gabapentin	302	114
Metoprolol Succinate	Metoprolol Succinate	297	95
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	288	288
Losartan Potassium	Losartan Potassium	287	96
Duloxetine Hcl	Duloxetine Hcl	261	84
Metformin Hcl	Metformin Hcl	221	70
Furosemide	Furosemide	199	66
Pantoprazole Sodium	Pantoprazole Sodium	171	59
Sertraline Hcl	Sertraline Hcl	168	57
Famotidine	Famotidine	157	61
Lorazepam	Lorazepam	156	44
Tramadol Hcl	Tramadol Hcl	156	29
Metoprolol Tartrate	Metoprolol Tartrate	154	55
Metformin Hcl Er	Metformin Hcl	136	49
Hydrochlorothiazide	Hydrochlorothiazide	131	58
Simvastatin	Simvastatin	123	43
Carvedilol	Carvedilol	120	32
Jardiance	Empagliflozin	120	38
Allopurinol	Allopurinol	110	39
Ozempic	Semaglutide	108	30
Albuterol Sulfate Hfa	Albuterol Sulfate	105	59
Tamsulosin Hcl	Tamsulosin Hcl	104	44
Fluticasone Propionate	Fluticasone Propionate	102	57
Potassium Chloride	Potassium Chloride	102	30
Prednisone	Prednisone	100	67
Telmisartan	Telmisartan	100	29
Pregabalin	Pregabalin	97	20
Eliquis	Apixaban	95	28
Ezetimibe	Ezetimibe	95	35
Montelukast Sodium	Montelukast Sodium	89	32
Meloxicam	Meloxicam	87	28
Clopidogrel	Clopidogrel Bisulfate	84	29
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	82	82
Glipizide Er	Glipizide	74	25
Oxycodone Hcl	Oxycodone Hcl	74	21
Trazodone Hcl	Trazodone Hcl	72	32
Mirtazapine	Mirtazapine	70	19
Warfarin Sodium	Warfarin Sodium	70	24
Estradiol	Estradiol	68	32
Alendronate Sodium	Alendronate Sodium	67	17
Diclofenac Sodium	Diclofenac Sodium	67	39
Breo Ellipta	Fluticasone/Vilanterol	63	20
Shingrix	Varicella-Zoster Ge/As01b/Pf	62	44
Citalopram Hbr	Citalopram Hydrobromide	61	20
Myrbetriq	Mirabegron	61	21
Escitalopram Oxalate	Escitalopram Oxalate	58	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	26
Alprazolam	Alprazolam	52	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	17
Finasteride	Finasteride	50	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	21
Bupropion Xl	Bupropion Hcl	49	25
Cefuroxime	Cefuroxime Axetil	49	39
Tizanidine Hcl	Tizanidine Hcl	49	16
Atenolol	Atenolol	47	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	18
Solifenacin Succinate	Solifenacin Succinate	47	15
Amoxicillin	Amoxicillin	46	36
Lamotrigine	Lamotrigine	46	13
Novolog Flexpen	Insulin Aspart	46	16
Paroxetine Hcl	Paroxetine Hcl	45	11
Donepezil Hcl	Donepezil Hcl	43	12
Memantine Hcl	Memantine Hcl	43	suppressed
Cephalexin	Cephalexin	42	29
Spironolactone	Spironolactone	41	13
Ondansetron Hcl	Ondansetron Hcl	40	20
Pravastatin Sodium	Pravastatin Sodium	40	14
Quetiapine Fumarate	Quetiapine Fumarate	40	12
Topiramate	Topiramate	40	12
Nitroglycerin	Nitroglycerin	39	23
Azelastine Hcl	Azelastine Hcl	38	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	28
Azithromycin	Azithromycin	37	24
Chlorthalidone	Chlorthalidone	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	34
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Buprenorphine	Buprenorphine	31	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	12
Cefdinir	Cefdinir	30	28
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Torsemide	Torsemide	30	12
Triamcinolone Acetonide	Triamcinolone Acetonide	30	22
Clonidine Hcl	Clonidine Hcl	29	suppressed
Ketoconazole	Ketoconazole	29	21
Synthroid	Levothyroxine Sodium	29	suppressed
Valsartan	Valsartan	29	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	11
Unifine Pentips	Pen Needle, Diabetic	27	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	11
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	11
Naproxen	Naproxen	25	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	13
Tradjenta	Linagliptin	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	22	12
Glipizide	Glipizide	22	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	21	21
Premarin	Estrogens, Conjugated	21	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Baclofen	Baclofen	19	suppressed
Fluconazole	Fluconazole	19	13
Oxybutynin Chloride Er	Oxybutynin Chloride	19	11
Colchicine	Colchicine	18	11
Mounjaro	Tirzepatide	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	12
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Linzess	Linaclotide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	11
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Nystatin	Nystatin	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error